New prestigious grants support Lario's unique portfolio of calcium channel programmes -- Indication expansion into Parkinson's disease, and PTSD (post-traumatic stress disorders) -- Builds on prior ...
Praxis Precision Medicines' ulixacaltamide (PRAX-944) is a potent and selective small molecule T-type Ca2+ channel blocker being developed for the potential treatment of essential tremor. ET is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results